Gavin Corcoran Receives Stock Award at Sio Gene Therapies Inc (SIOX) — SEC Form 4, Mar 19, 2021

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Gavin Corcoran

Officer

TXN 2021-03-17 · FILED 2021-03-19

Equity Position 25.8K sh 9,791 → 25,792

Equity Change +163.4% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Sio Gene Therapies Inc

SIOX CIK 0001636050

Reporting Owner

Name	Relationship
Gavin Corcoran CIK 0001745995	Officer

Gavin Corcoran at Sio Gene Therapies Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Sio Gene Therapies Inc

Award

—

View

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common Stock	2021-03-17	A - Award/Grant	16,001 A	$0.00	—	25,792	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitsF1 F1 F1		2021-03-17	D - Return to Issuer	16,001 D	$0.00		16,001 Common Stock	Direct

Footnotes (1)

F1: Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted. Show more

Institutional Holders

Largest by reported value

Other insiders at Sio Gene Therapies Inc

GET /v1/forms/4/0001636050-21-000029 API docs